In this context, Remick et al. demonstrated that mice at low risk of death due to sepsis had decreased survival when treated with IL-18 binding protein.(8) Osuchowsk et al.(7) demonstrated that early and accurate survival prediction allows targeted immunosuppression using dexamethasone, improving survival in the late phase. This evidence concerns the gene IL18 and Sepsis.